Sector consensus Charles River Laboratories International, Inc.

Stocks

Market Closed - NYSE Other stock markets 21:00:02 02/07/2026 BST			5-day change	1st Jan Change
230.69 ^USD	+0.70%		+6.92%	+15.65%

07-01	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing	MT
07-01	Argus Raises Price Target on Charles River Laboratories International to $250 From $200, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	215.33	-6.66%	15
LONZA GROUP AG	665.48	+15.9%	23
REVOLUTION MEDICINES, INC.	197.18	+4.2%	22
IQVIA HOLDINGS INC.	226.47	+9.39%	19
BEONE MEDICINES AG	412.38	+38.55%	27
CELLTRION, INC.	255,593.25	+39.21%	24
ASCENDIS PHARMA A/S	255.88	+6.46%	18
MEDPACE HOLDINGS, INC.	443.5	-20.46%	12
EUROFINS SCIENTIFIC SE	71.03	+2.41%	14
IONIS PHARMACEUTICALS, INC.	105.91	+29.48%	23
ABIVAX	130.06	-3.66%	6
ICON PUBLIC LIMITED COMPANY	178.31	+3.04%	16
BIO-TECHNE CORPORATION	69.08	-2.47%	12
TEMPUS AI, INC.	66.06	+9.61%	16
APOGEE THERAPEUTICS, INC.	130.53	-1.79%	12
KYMERA THERAPEUTICS, INC.	123.76	+9.03%	21
ALKERMES PLC	50.19	-8.05%	16
PRAXIS PRECISION MEDICINES, INC.	619.11	+94.37%	18
PROTAGONIST THERAPEUTICS, INC.	118.69	-9.82%	13
Average	13,666.96	+10.99%	17
Weighted average by Cap.	20,301.81	+13.11%	19